MREO
Mereo BioPharma Group plc American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Mereo BioPharma Group (MREO) Stock: Buy, Sell, or Hold?
$0.31
0.00 (-0.52%)
âŧ
5d:
+8.77%
30d:
-1.45%
90d:
-4.36%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
51/100
Position
FAIR
30-Day Fair Range
$0.28 â $0.34
Position: FAIR
Forward P/E & Valuation
-55.8x
Next 12M consensus est.
Wall Street Target
$1.98
+545.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.27 / $0.32
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: MREO is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When MREO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MREO is currently trading at $0.30, which is considered fair relative to its 30-day fair value range of $0.28 to $0.34.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.32.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.98 (+545.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MREO is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.32.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.98 (+545.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.28 -
$0.34
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$0.28 -
$0.34
Current vs Trading Range
FAIR
Support Level
$0.27
Resistance Level
$0.32
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 545.0% below Wall St target ($1.98)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-55.75
Wall Street Target
$1.98
(+545.0%)
Share MREO Analysis
Share this live MREO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (MREO)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Feb 18, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on MREO are bearish (sentiment score -0.46) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:41 PM ET
Data refreshes hourly during market hours. Next update: 4:41 PM
Data refreshes hourly during market hours. Next update: 4:41 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MREO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
RAPP
Rapport Therapeutics, InâĻ |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MREO Research Pages
